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Abstract. Among the many target genes of the tran- 
scription factor NF-KB are p53 and c-myc, both of 
which are involved in apoptosis. This prompted us to 
investigate the role of NF-KB in this process. We report 
that NF-KB is potently activated upon serum starvation, 
a condition leading to apoptosis in 293 cells. Similar to 
Bcl-2, a transdominant-negative mutant of the NF-KB 
p65 subunit partially inhibited apoptosis, indicating a 
direct involvement of the transcription factor in induc- 
tion of cell death. As expected, the p65 mutant sup- 
pressed KB-dependent gene expression. Surprisingly, 
transiently or stably overexpressed Bcl-2 had the same 
effect. The transcription inhibitory activity of the two 
proteins correlated with their cell death protective po- 
tential. Like Bcl-2, the related protein Bcl-XL but not 
Bcl-xs was able to suppress KB-dependent transcrip- 
tion. Bcl-2 inhibited NF-KB activity by an unusual 
mechanism. It did not prevent the release of IKB in the 
cytoplasm but down-modulated the transactivating po- 
tential of nuclear p65. These data show that NF-KB can 
participate in apoptosis. We suggest that at least part of 
the anti-apoptotic potential of Bcl-2 may be explained 
from a hitherto undiscovered activity of Bcl-2 in con- 
trolling nuclear gene expression. 
OPTOSIS is a highly controlled form of cell death that 
involves an altruistic genetic program for the ben- 
efit of the  organism.  Recently, this  process  has 
gained considerable interest because of its involvement in 
embryonic development, tissue homeostasis, autoimmune 
diseases,  T cell depletion in AIDS, chemotherapeutic drug- 
induced  killing  of  cancer  cells,  and  neurodegeneration 
(Kerr et al., 1994; Raft, 1992; Cohen, 1991; Ameisen, 1994; 
McConkey and  Orrenius,  1989).  The  molecular mecha- 
nisms underlying programmed  cell  death  are  under  in- 
tense investigation. Beginning with blebbing of the plasma 
membrane, endonucleolytic degradation of genomic DNA 
occurs,  which culminates in  the  condensation and  frag- 
mentation of the nucleus (Arends and Wyllie, 1991). Ulti- 
mately, the cells are removed by phagocytes without pro- 
voking an inflammatory response. Because apoptosis is an 
active process often requiring protein synthesis, transcrip- 
tional control of specific "death genes" is likely to play a 
crucial regulatory role (Schwartz and Osborne,  1993).  In 
the past years, several gene products have been identified 
that either promote or inhibit apoptotic processes. 
Important gene products that interfere with apoptosis 
include Bcl-2 and related members of the Bcl-2 family (for 
reviews  see  Korsmeyer, 1992; Reed,  1994; Vaux,  1993; 
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Nunez and Clarke, 1994). Experimental overexpression of 
Bcl-2 has been shown to protect cells from apoptosis in a 
great number of different systems. Aberrant overexpres- 
sion of Bcl-2 as often observed in tumors might rescue pre- 
cancerous cell clones from apoptotic elimination. This fa- 
cilitates  the  accumulation  of  additional  mutations  that 
might ultimately lead to overt malignant transformation. 
In that way, anti-apoptotic proteins, such as Bcl-2, consti- 
tute a new class of oncogenes (Korsmeyer, 1992). The sub- 
cellular distribution of Bcl-2 is unusual for an oncogene. It 
is present in the nuclear membrane, the ER, as well as in 
mitochondria (Hockenbery et al., 1990; Krajewski et al., 
1993; de Jong et al., 1994). Human Bcl-2 can functionally 
substitute for ced-9, an apoptosis-preventing gene in Cae- 
norhabditis  elegans, showing a high functional and struc- 
tural conservation of the apoptotic pathway during evolu- 
tion (Vaux et al., 1994). 
Despite intense investigations, however, the mode of ac- 
tion of Bcl-2 remains enigmatic. Interactions of Bcl-2 with 
related proteins such as Bax, Bcl-x,  and others, which ei- 
ther suppress or promote cell death, may determine the 
sensibility of cells to undergo apoptosis (Oltvai et al., 1993; 
Boise et al., 1993). By coimmunoprecipitation and trans- 
fection studies, it has recently been reported that Bcl-2 as- 
sociates with components of signal transduction cascades, 
such as the GTPase protein R-Ras, the functionally associ- 
ated protein kinase Raf-1, and E1B-associated molecules 
(Fernandez-Sarabia and Bischoff, 1993; Wang et al., 1994, 
1995; Boyd et al., 1994). This suggests that Bcl-2 may inter- 
fere with events of signal transduction and gene expres- 
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studies have suggested that  Bcl-2 may directly interfere 
with processes of the execution phase of cell death (Hock- 
enbery et al., 1993; Kane et al., 1993; Jacobson et al., 1994). 
The distribution of Bcl-2 in intracellular membranes has 
led to speculations that Bcl-2 interacts with electron trans- 
fer reactions and the formation of reactive oxygen inter- 
mediates (ROIs). t It has been suggested that Bcl-2 has an- 
tioxidant properties and directly impairs oxidative stress, 
which is often observed in response to a variety of apop- 
totic stimuli (Hockenbery et al.,  1993; Kane et al.,  1993). 
Recent studies, however, show that Bcl-2 may be also pro- 
tective against apoptosis in hypoxic conditions where no 
ROI formation occurs (Jacobson and Raft, 1995; Shimizu 
et al., 1995). 
The important role of oxidative events has been further 
emphasized for a variety of biological processes, such as 
signal transduction and gene expression. Numerous stud- 
ies have demonstrated that in particular the activation of 
NF-KB, an important transcription factor involved in cellu- 
lar defense mechanisms requires oxidative signaling  (for 
review see Baeuerle and Henkel, 1994; Schulze-Osthoff et 
al.,  1995).  NF-KB is activated in response to a great num- 
ber of stimuli, most of which represent pathogenic stresses 
(Baeuerle, 1991). A common intracellular reaction elicited 
by most, if not all, stimuli activating NF-KB is an increased 
production of ROIs leading to oxidative stress. Treatment 
of several celt lines with H202 has indeed been shown to 
activate NF-KB (Schreck et al.,  1991; Meyer et al.,  1993), 
and activation of the factor in response to all stimuli tested 
so far could be blocked by a variety of structurally unre- 
lated antioxidative compounds (for review see Meyer et al., 
1994). In the course of its cytoplasmic activation, the spe- 
cific inhibitor of NF-KB, IKB-et, is phosphorylated and pro- 
teolytically degraded  (Sun et al.,  1993;  Beg et al.,  1993; 
Henkel et al., 1993; Traenckner et al., 1994). This exposes 
nuclear  localization  sequences  in  the  remaining  NF-KB 
heterodimer (Beg and Baldwin, 1993; Zabel et al.,  1993), 
leading to nuclear translocation and subsequent binding of 
NF-KB to DNA regulatory elements within NF-KB target 
genes. 
Because most NF-KB stimuli represent cellular stresses, 
some of which induce apoptosis, and because some of the 
NF-KB target genes, such as p53 (Wu and Lozano, 1994) 
and c-myc (La Rosa et al., 1994), have been implicated in 
apoptosis,  we  investigated whether  a  classical  apoptotic 
stimulus would also activate NF-KB. We report here that 
NF-KB is specifically activated in the course of apoptosis 
induced by serum withdrawal.  This activation of NF-KB 
was demonstrated to be necessary for the execution of the 
apoptotic program.  Overexpression of Bcl-2,  which was 
able to prevent apoptosis, specifically repressed NF-KB- 
dependent transactivation by attenuating the transactiva- 
tion potential of its p65 subunit. Our data indicate that ac- 
tivation of NF-KB and KB-dependent gene transcription is 
involved in induction of apoptosis after serum deprivation. 
1.  Abbreviations  used  in  this paper:  CAT, chloramphenicol acetyltrans- 
ferase; CMV, cytomegalovirus; EMSA, electrophoretic mobility shift as- 
say; HIV, human immunodeflciency virus; ICE, interleukin-ll3 converting 
enzyme; IL, interleukin; Luc, luciferase; LTR, long terminal repeat; PMA, 
phorbol  12-myristate  13-acetate;  ROI,  reactive  oxygen  intermediate; 
RSV, Rous sarcoma virus; TNF, tumor necrosis factor. 
Materials and Methods 
Cell Culture 
The human embryonic kidney cell line 293 and COS-7 cells were main- 
tained in DME medium supplemented with 10% FCS and antibiotics. The 
interleukin (IL)-2-dependent mouse T cell line Clone29 (Krammer et al., 
1983) was grown in RPMI 1640 medium supplemented with 10% FCS, 50 
~M 2-mercaptoethanol, and 50 IU/ml recombinant IL-2. For apoptosis as- 
says, 2  ×  105 cells were seeded onto 60-mm tissue-culture plates (Nunc 
GmbH, Wiesbaden, Germany) and grown on coverslips for 48 h until 60% 
confluency was reached. After serum withdrawal, cells were stained with 
propidium iodide as described (Jacobson et al., 1993), except that 5 ng/ml 
propidium iodide was used. Coverslips were mounted and photographed 
with a fluorescence microscope (Axiovert; Zeiss, Oberkochen, Germany). 
Gel Electrophoresis  of Fragmented DNA 
Cells (2 x  106) were seeded on 10-cm petri dishes and incubated for 24 h 
before serum was withdrawn. For analysis of genomic DNA, cells were 
gently scraped off after the indicated time points and collected together 
with the nonattached cells in the supernatant. Cells were resuspended in 
0.25 ml TBE (45 mM Tris-borate, 1 mM EDTA, pH 8.0) containing 0.25% 
NP-40 and 0.1 mg/ml RNAse A. After incubation at 37°C for 30 min, ex- 
tracts were treated with 1 mg/ml proteinase K for an additional 30 min at 
37°C. Then, 30 I~l of the extracts were loaded on a 1.7% agarose gel and 
run in the presence of 0.5 Ixg/ml ethidium bromide. 
Plasmid Constructs 
The vector RcCMV-Bcl-2, which directs the synthesis of the human Bcl-2 
protein from the cytomegalovirus (CMV) enhancer, was obtained by sub- 
cloning a  PCR-generated cDNA fragment containing the full coding re- 
gion of bcl-2 into the mammalian expression vector RcCMV (Invitrogen 
BV, De Schelp, The Netherlands). The insert was sequenced and found to 
contain no mutation relative  to  the published sequence (Cleary  et  al., 
1986).  Similar CMV enhancer-driven constructs were generated for Bcl- 
x L and  Bcl-x  s  expression plasmids (Boise et  al.,  1993).  The  constructs 
Ga14-p65286-55° and Gal4-VP16 have been described (Schmitz and Bae- 
uerle, 1991) and contained the DNA-binding and dimerization domain of 
the yeast transcription factor Gal4 fused to the COOH-terminal transacti- 
vation domain of p65 and the herpes simplex virus transactivator VP16, 
respectively. The NF-KB reporter gene plasmid J16 contained two KB sites 
upstream from a  truncated c-fos  promoter controlling chloramphenicol 
acetyltransferase (CAT) expression, and the construct J32 had two mu- 
tated KB sites (Pierce et al., 1988). The mutant p65Sal lacking the transac- 
tivating COOH-terminus of p65 was generated by deleting the XbaI/SalI 
fragment from the parental  vector RcCMVp65  (Schmitz and  Baeuerle, 
1991), followed by a fill-in with Klenow polymerase and insertion into the 
expression vector RcCMV. The expression vector encoding vaccinia virus- 
derived CrmA protein has been described (Los et al., 1995). 
Transfections  and CAT Assays 
Cells were transfected by the calcium phosphate coprecipitation method 
in 60-mm plates as described (Roussel et al., 1984) with 2 I~g reporter plas- 
mid: J16, its mutant derivative J32, or RSV-CAT, which served as an NF-KB 
noninducible construct. Where indicated, 2  ~g Bcl-2 expression plasmid 
was cotransfected. To adjust for equal amounts of transfected DNA, ap- 
propriate amounts of RcCMV-luciferase (Luc) (Pahl and Baeuerle, 1995) 
were added. After 4 h, the medium was changed, and the cells were stimu- 
lated with tumor necrosis factor (TNF) (200 U/ml; Boehringer Mannheim 
GmbH,  Mannheim, Germany)  and/or  phorbol  12-myristate  13-acetate 
(PMA) (50 ng/ml; Sigma Chemical Co., Deisenhofen, Germany) for an ad- 
ditional  4  h.  Transfections  with  the  human  immunodeficiency  virus 
(HIV)-long terminal repeat (LTR)-Luc (Schwartz et al., 1990)  were per- 
formed with 500 ng reporter plasmid and 6 I~g expression plasmid. Here, 
the  medium was  changed  after  overnight incubation.  Cells were  har- 
vested, and protein extracts were prepared by three freeze-thaw cycles. 
Equal amounts of protein were used in a CAT assay (Gorman et al., 1982) 
or luciferase assay (Pahl and Baeuerle, 1995). 
Clones stably expressing the Gal4  fusion proteins were obtained  by 
cotransfecting 2 I-~g  of the hygromycin resistance plasmid pMEP4 (Invitrogen 
BV)  together with either the expression vector Ga14-p65286"5s° or Ga14- 
VP16 (Schmitz and Baeuerle, 1991). Selection was performed in 100 ~g/ml 
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and CrmA were generated by selection  in 200  ~g/ml G-418 (GIBCO 
BRL, Eggenstein, Germany) for 2 wk, after which individual clones were 
isolated. Bcl-2 expression  was confirmed by immunofluorescence  as de- 
scribed (Zabel et al., 1993) with an mAb against Bcl-2 (Cambridge  Re- 
search Biochemicals, Northwick, UK). 
Cell Extracts and Mobility Shift Assays 
Analysis  of DNA-binding activities  by electrophoretic mobility  assays 
(EMSAs)  was performed as described  (Zabel et al., 1991) using 2  p~g 
poly(dI-dC)  (Sigma Chemical Co.) as nonspecific competitor DNA. Bind- 
ing reactions were electrophoresed  on a native 4% polyacrylamide gels in 
0.5X TBE buffer to separate bound and unbound DNA probe. The bind- 
ing reaction contained 10,000 cpm. of 32p-labeled double-stranded oligo- 
nucleotides with a high affinity NF-KB binding or an octamer-binding mo- 
tif  (Promega,  Heidelberg,  Germany).  Nuclear  extracts  of  cells  were 
prepared as described (Schreiber  et al., 1989). The protein content was 
measured by the method of Bradford (1976). 
Western Blotting 
IKB-ct was detected in total cell extracts by Western blotting as described 
(Traenckner et al., 1994). Briefly, proteins were separated by a reducing 
10%  SDS-PAGE, transferred to  Immobilon  P  membranes (Millipore 
GmbH, Eschborn, Germany), and stained with an affinity-purified rabbit 
serum directed against human IKB-ct.  Bound antibody was decorated with 
goat anti-rabbit/HRP conjugate (Bio-Rad  Laboratories GmbH, Munich, 
Germany) followed by enhanced chemoluminescent  staining using ECL 
reagents (Amersham Buchler  GmbH  &  Co  KG,  Braunschweig,  Ger- 
many). 
Results 
Serum Withdrawal Causes Apoptosis in 293 Cells, 
Which Is Attenuated by Bcl-2 
We studied programmed cell death in the human kidney 
epithelial carcinoma cell line 293.  These cells underwent 
apoptosis  after  serum  withdrawal  (Fig.  1  A).  3  d  after 
omission  of serum,  nuclear uptake  of propidium  iodide 
was apparent in N10% of cells. On day 5, 50% of cell nu- 
clei were stained. On day 6, almost all cells were apoptotic 
(data not shown). The stained cells displayed disintegrated 
nuclei and nonrandom DNA fragmentation as assessed by 
agarose gel electrophoresis of genomic DNA  (Fig.  1  B). 
Bcl-2 was  able  to significantly suppress  apoptosis in 293 
cells (Fig. 1 A). In three cell clones stably overexpressing 
Bcl-2, apoptosis measured at day 5 was reduced to about 
threefold as compared to the parental  line. While Bcl-2 
was barely detected in parental 293 cells, the three clones 
showed a strong perinuclear and faint cytoplasmic Bcl-2- 
specific immunofluorescent staining,  similar to what  has 
been reported in other systems (Chen-Levy et al.,  1989; 
Hockenbery et  al.,  1990;  Krajewski  et  al.,  1993).  These 
data establish 293 cells as a  suitable model to investigate 
apoptotic cell death after serum withdrawal. 
Induction of  Apoptosis Correlates with Activation 
of NF-KB 
Using the EMSA,  we analysed the DNA-binding  activity 
of  NF-KB  in  293  cells  after  serum  starvation.  Equal 
amounts of protein from nuclear extracts were analyzed 
with a 32p-labeled DNA probe encompassing one NF-KB- 
binding motif from the HIV-1 enhancer. As shown in Fig. 
2 A, apoptosis in serum-starved 293 cells was accompanied 
by a very strong induction of a nuclear KB-binding activity 
starting at day 3. Two other faster-migrating binding activ- 
ities were nonspecific and remained unaffected between 
days 1 and 5 after serum withdrawal. To analyze the speci- 
ficity of the induced DNA-binding complex, competition 
and supershift analyses were performed. Formation of the 
slowly migrating complex was competed by an 100-fold ex- 
cess of unlabeled KB oligonucleotide (Fig. 2 B, lane 3) but 
not by an oligonucleotide mutated in the KB-binding site 
(lane 2). As demonstrated by immunoreactivity with spe- 
cific antisera  in  supershift  assays,  the  induced  protein- 
DNA complex of the slowest mobility contained the p50 
Figure  1.  Induction  of  apopto- 
sis in  293  cells by  serum with- 
drawal. (A) The effect of serum 
starvation and Bcl-2 overexpres- 
sion on the survival of 293 cells. 
Parental  293  cells,  as  well  as 
three  cell  lines  stably  overex- 
pressing Bcl-2 (clones 1-3), were 
cultured for the indicated times 
under  serum-free  conditions. 
Apoptotic cells were visualized 
by  propidium  iodide  staining, 
and  at  least  500  cells  were 
counted for each condition. The 
mean value and SD from three 
independent  measurements  of 
each cell line are shown. (B) In- 
duction  of  internucleosomal 
DNA  fragmentation  by  serum 
withdrawal.  Parental  293  cells 
were cultured in serum-free me- 
dium.  After the  indicated time 
points, DNA was extracted and 
analyzed by agarose gel electro- 
phoresis  in  the  presence  of 
ethidium bromide. 
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factor withdrawal. (A) Effect of serum starvation on NF-KB acti- 
vation in 293 cells. Equal amounts (6 Ixg) of nuclear cell extracts 
were subjected to EMSAs with a 32p-labeled oligonucleotide en- 
compassing the NF-KB binding site of the HIV-1-LTR. In lane 1, 
a nuclear extract of 293 cells cultivated with 5% serum was ana- 
lyzed.  In lanes 2--6,  extracts of cells serum starved for  1 to 5  d 
were  analyzed.  The NF-KB  specific complex (filled arrow) and 
the free probe (open arrow) are indicated. (B) Competition anal- 
ysis. Reaction mixtures containing extracts of cells cultured for 5 d 
in serum-free conditions were either left untreated (lane 1) or in- 
cubated with a  100-fold excess of unlabeled mutated (lane 2) or 
wild-type  KB-specific oligonucleotide  (lane 3).  A  section of the 
fluorogram is shown.  (C)  Characterization of the induced pro- 
tein-DNA complex. The extract from day 5 was incubated in an 
EMSA-binding reaction with 1 Ixl of control antiserum (Control) 
directed against IKB (Henkel et al., 1993), p50, p65, or c-Rel, re- 
spectively. The NF-KB signal is indicated by a  filled arrowhead. 
(D)  Oct-l-binding activity during serum withdrawal. The same 
nuclear extracts and protein amounts as in A  were analyzed with 
an Oct-l-specific oligonucleotide in an EMSA. (E) Effect of IL-2 
withdrawal on NF-KB activation in Clone29 T  cells. Extracts of 
cells incubated for the indicated times in the absence of IL-2 were 
analyzed for NF-KB activation in an EMSA as described in A. 
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anti-p50 and anti-p65 sera impaired formation of the pro- 
tein-DNA complex, while it did not react with anti-c-Rel 
nor with an irrelevant control serum (Fig. 2 C). In contrast, 
the  DNA-binding  activity of the  ubiquitous  factor Oct-1 
was not affected during serum withdrawal  (Fig.  2  D). In 
the same nuclear extracts, which were assayed for NF-KB 
activity, Oct-l-binding activity was present at very similar 
levels at all time points. In addition, we could not observe 
induction  of the DNA binding activity of AP-1  upon se- 
rum withdrawal (data not shown), although c-los or c-jun 
gene induction has been shown to correlate with apoptosis 
(Colotta et al., 1992; Smeyne et al., 1993; Estus et al., 1994; 
Ham et al., 1995). 
To analyze whether activation of NF-KB during apopto- 
sis was restriced to 293  cells, we furthermore performed 
experiments  in  the  IL-2-dependent T  cell  line  Clone29. 
When  deprived  of  IL-2,  these  cells  undergo  apoptosis 
within 48 h. As in 293 cells, growth factor withdrawal also 
led  to a  significant  activation of NF-KB in  Clone29  cells 
(Fig. 2 E). 
These results show a  striking temporal correlation be- 
tween the onset and progression of apoptosis and the acti- 
vation of NF-KB. In contrast to other stimuli, such as phor- 
bol esters or cytokines, which rapidly activate NF-KB for 
less than a few hours (data not shown), growth factor with- 
drawal caused a very persistent activation of NF-KB. In ac- 
cordance, serum starvation led to a rather slow proteolytic 
degradation of the inhibitory subunit IKB-a, as shown by 
Western blotting of total cell extracts (Fig. 3 A). To ana- 
lyze whether  serum starvation was  able  to  induce  func- 
tional  NF-KB-controlled  gene  expression,  reporter  gene 
assays were performed. A  stably integrated luciferase re- 
porter gene under the control of the HIV-LTR, which har- 
bors two essential NF-KB-binding sites, was strongly acti- 
vated upon serum starvation of 293 cells (Fig. 3 B). These 
results show that NF-KB induced upon apoptosis was tran- 
scriptionally active. 
NF-~cB Activation Is Required  for the Induction 
of  Apoptosis 
To investigate the significance of NF-KB activation for the 
induction  and progression of apoptosis, we constructed a 
dominant-negative mutant of the p65 NF-KB subunit lack- 
ing  the  transactivating  COOH-terminal  81  amino  acids. 
This mutant, called p65Sal, was still able to heterodimerize 
with p50 and to bind to KB motifs, but was unable to trans- 
activate KB-dependent gene expression (data not shown; 
compare Fig. 4 B). When p65Sal was stably overexpressed 
in 293 cells, a partial but significant reduction of apoptotic 
death was observed in three independent clones (Fig. 4 A). 
In comparison to Bcl-2, however, protection was less effi- 
cient. These results indicate that the activation of NF-KB 
observed after growth factor deprivation was involved in 
inducing apoptosis. 
Bcl-2 Supresses the Transcriptional Potential of  NF-~B 
As  shown  in  Fig.  4  B,  p65Sal  partially  suppressed  the 
transactivation of a KB-dependent CAT reporter construct 
after stimulation with the phorbolester PMA. Surprisingly, 
not  only the  transdominant-negative  mutant  of p65  but 
Figure 3.  (A) Effect of serum withdrawal  on the degradation of 
IKB-et. 293 cells were kept serum free for the indicated periods of 
time.  Total cell extracts were electrophoresed under reducing, 
denaturating conditions, stained with affinity-purified anti-IKB-et, 
and visualized by enhanced  chemoluminescent  staining.  (B) Ef- 
fect of serum withdrawal  on the activity of a  KB-dependent  re- 
porter gene. 293 cells stably transfected with the luciferase  gene 
under control of the HIV-LTR were cultivated  without serum. 
NF-KB activity indicated  as relative  light units (RLU) was mea- 
sured every day and normalized according to protein content.  A 
representative experiment is shown. 
also  Bcl-2 was  able  to  suppress NF-KB-dependent  tran- 
scriptional activation in 293  cells (Fig. 4  B). This was not 
due to differences in transfection efficiency, since a  Rous 
sarcoma virus (RSV) LTR-controlled CAT reporter con- 
struct, which is independent  of NF-KB, showed equal ac- 
tivity in all cell clones when compared to the parental cell 
line  (data  not  shown).  In  addition,  293  cells  expressing 
solely the  neomycin resistance  gene  revealed  no  differ- 
ences in  NF-KB  activation. Fig.  4  further shows that  the 
ability of Bcl-2 to suppress  KB-dependent transactivation 
correlated with its superior capability to repress apoptosis 
(compare Fig. 4, A  and B). 
The inhibitory effect of transiently overexpressed Bcl-2 
on  NF-KB  activation  was  also  observed  in  response  to 
other potent NF-KB-activating stimuli, such as a combina- 
tion of TNF and PMA (Fig. 5 A). Likewise, NF-KB activa- 
tion  by stimulation  with  PMA  alone  was  inhibited  in  a 
dose-dependent  manner  by Bcl-2  expression  (Fig.  5  A). 
Transient transfection of a  CMV enhancer-controlled lu- 
ciferase expression vector (RcCMV-Luc), which was used 
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and on the transactivation  of NF-KB. (A) The effect of overex- 
pression  of the  transdominant-negative  mutant  p65Sal  and  of 
Bcl-2 on the survival of 293 cells after serum withdrawal. Parental 
293  cells, as well as each three independent  cell clones  stably 
overexpressing Bcl-2 or p65Sal (clones 1-3), were cultured for 5 d 
under serum-free conditions. As a control, cells stably expressing 
the neomycin resistance  gene (293-Neo) were used.  Apoptotic 
cells were visualized by propidium iodide  staining and counted. 
The mean value and SD from three independent measurements 
of apoptotic cells are shown. (B) Repression of NF-KB transacti- 
vation in cell clones overexpressing p65Sal or Bcl-2. Cell lines sta- 
bly expressing p65Sal or Bcl-2 were transiently transfected with a 
NF-KB-dependent CAT construct.  After 4 h of stimulation  with 
PMA,  cells were harvested  and  CAT assays were performed. 
Mean values of duplicate  experiments are shown relative to the 
uninduced  level. 
to adjust for equal amounts of transfected DNA, had no 
effect. The inhibitory effect of Bcl-2 relied on intact NF- 
KB-binding motifs,  as  it  was  neither  observed with  the 
CAT construct  harboring two mutated  inactive  KB sites 
nor with an RSV enhancer-controlled CAT reporter gene 
(Fig. 5 B). 
We further examined the effect of Bcl-2 on NF-KB activa- 
tion in serum-starved cultures. Fig. 5 C shows that NF-KB- 
mediated transactivation in response to serum deprivation 
was  dose  dependently  inhibited  in  Bcl-2-overexpressing 
cells. Hence, in a fashion similar to the rapid NF-KB induc- 
ers TNF and PMA, Bcl-2 was able to repress NF-KB in re- 
sponse to a slow but more persistent stimulus of NF-KB ac- 
tivation. Inhibition of NF-KB by Bcl-2 was also observed in 
COS-7 cells (Fig. 5 D), showing that the effects were not 
restricted to a single cell type. 
Furthermore,  we found that  the Bcl-2-related protein, 
Bcl-XL, which also prevents apoptosis (Boise et al., 1993), 
was equally capable to suppress  KB-dependent transacti- 
vation (Fig. 6). Its splice variant, Bcl-xs, which is devoid of 
an apoptosis-suppressing function, however, was unable to 
inhibit NF-KB activation. These data show that Bcl-2 and 
related proteins can specifically influence gene expression 
in  the  nucleus  by attenuating  the  expression  of NF-KB- 
controlled genes. These findings further support a correla- 
tion between anti-apoptotic and NF-KB-inhibiting activi- 
ties of Bcl-2 proteins. 
Recently, proteases of the interleukin-l[3 converting en- 
zyme (ICE) family have been implicated in apoptosis in- 
duced by a variety of stimuli, such as Fas and TNF recep- 
tor ligation, and growth factor withdrawal (Los et al., 1995; 
Tewari and Dixit, 1995; Hsu et al., 1995; Gagliardini et al., 
1994).  The poxvirus protein CrmA encodes a specific ser- 
pin  class  inhibitor  of  ICE  proteases  (Ray  et  al.,  1992; 
Schulze-Osthoff et al., 1996).  To investigate whether ICE 
proteases were  involved in  apoptosis and NF-KB activa- 
tion,  we  therefore  stably  expressed  CrmA  in  293  cells. 
Two clones were selected and found to overexpress CrmA 
(data not shown).  As shown in Fig. 7,  CrmA neither af- 
fected induction  of apoptosis nor activation of NF-KB in 
serum-starved 293 cells. Although we cannot exclude that 
the level of CrmA expression was insufficient, the results 
indicate that induction of apoptosis and NF-KB activation 
do presumably not involve ICE proteases in 293 cells. 
Bcl-2 Does Not Interfere with DNA Binding 
and Nuclear Transport of NF-KB 
Bcl-2 has been reported to counteract apoptosis by induc- 
ing an antioxidant pathway (Hockenbery et al., 1993).  Be- 
cause the dissociation of the cytoplasmic NF-KB-IKB com- 
plex  is  induced  by  ROIs  and  inhibited  by  antioxidants 
(Schreck et al., 1992b), we investigated whether Bcl-2 sup- 
presses the activation of NF-KB by interfering with the re- 
lease of IKB in the cytoplasm. As shown in Fig. 8 A, 293 
cells overexpressing Bcl-2 showed  the  same level of nu- 
clear NF-KB DNA-binding activity after TNF stimulation 
as the parental cell line. The kinetics of activation of NF-KB 
DNA binding were also not significantly altered by Bcl-2 
overexpression  (data  not  shown).  Hence,  Bcl-2  overex- 
pression  presumably does  not  interfere  with  the  redox- 
controlled release of IKB in the cytoplasm, but must affect 
the activity of IKB-released, nuclear NF-KB. 
Bcl-2 Represses the Activity of the COOH-terminal 
Transactivation  Domain of  p65 
The  strong transcriptional  activation by NF-KB  is  medi- 
ated by transactivating sequences in the COOH-terminal 
portion of the p65 subunit (Schmitz and Baeuerle, 1991). We 
therefore investigated the possibility that Bcl-2 modulates 
the activity of the COOH-terminal transactivating domain 
of p65. To this  end,  Ga14-p652865s°, a  fusion plasmid en- 
coding the DNA-binding domain of the yeast transcription 
factor Gal4 and the transactivation domain of p65, was sta- 
bly expressed in 293 cells. Six independent clones selected 
The Journal of Cell Biology, Volume 134, 1996  18 Figure 5.  The effect of overexpression of Bcl-2 on the transcriptional activity of NF-KB. (A) The effect of Bcl-2 expression on NF-KB- 
mediated transactivation in 293 cells. Cells were cotransfected with the NF-KB CAT reporter gene plasmid J16 and 1,000 ng of either a Bcl- 
2 expression plasmid (Bcl-2) or the control vector RcCMV-Luc (-) (left). In the titration experiment (right), 100, 200, 500, and 1,000 ng 
of Bcl-2 expression plasmid were used, and the total amount of DNA was adjusted to 2  Ixg with the control plasmid. After stimulation 
for 4 h with PMA and/or TNF, CAT assays were performed. The mean from two duplicate experiments is shown. (B) Specificity  of Bcl- 
2-mediated repression. 293 cells were treated as in A  except that two other reporter plasmids were tested. In addition to the NF-KB 
CAT plasmid (KB-CAT), a homologous reporter plasmid with two mutated NF-KB binding sites (KBmut-CAT) was used, as well as 
RSV-CAT, which directs the synthesis of the CAT gene under control of the NF-KB-independent RSV long terminal repeat. (C) The 
effect of Bcl-2 overexpression on NF-KB activity in response to serum starvation. 293 cells stably expressing an HIV-LTR controlled lu- 
ciferase construct were transiently transfected with increasing concentrations (0, 100, 200, 500, and 1,000 ng) of the Bcl-2 expression 
plasmid. The total amount of transfected DNA was adjusted to 2  I~g with a control plasmid. 12 h after transfection, cells were serum 
starved for an additional 72 h or left in the presence of serum. Mean values of NF-KB activity indicated as relative light units (RLU) 
from duplicate experiments are shown. (D) The effect of Bcl-2 overexpression on NF-kB activity in COS-7 cells. Cells were cotrans- 
fected with an HIV-LTR luciferase construct and increasing amounts of the Bcl-2 expression plasmid as described in C. 12 h after trans- 
fection, cells were stimulated with PMA and harvested after an additional 4 h. Mean values of NF-KB activity indicated as relative light 
units (RLU) from triplicate experiments are shown. 
for stable Ga14-p65 expression were then transiently trans- 
fected with a  Gal4-controlled reporter gene construct. As 
a control, cells overexpressing GaI4-VP16, a fusion protein 
containing  an  NF-KB-independent,  constitutively  active 
transactivation domain, were analyzed. Fig. 8 B  shows that 
in the individual clones, Gal4-dependent reporter gene ex- 
pression was activated to distinct levels. In all Ga14-p65- 
expressing clones, cotransfection of Bcl-2  attenuated  the 
Gal4-dependent activity between 56% and 83%  (Fig. 8 B). 
This inhibitory effect of Bcl-2 was stronger in cell lines ex- 
pressing low levels of Gal4-p65  than  in  those  expressing 
higher levels (compare, for instance, clones 2  and 4). No 
inhibition,  however,  was  observed  in  cells  expressing 
Ga14-VP16,  demonstrating that  the  effects of Bcl-2 were 
specific to NF-KB (Fig. 8 C). Thus, the strong inhibitory ef- 
fect of Bcl-2 on Ga14-p65 indicates that the COOH-termi- 
nus of p65 NF-KB is the primary target for the gene regula- 
tory activity of Bcl-2. 
Since Bcl-2 has been found to be associated in part with 
the nuclear pore complex (Krajewski et al., 1993; de Jong 
Grimm et al. Bcl-2 and NF-KB  19 Figure 6.  The effect of Bcl-2-related proteins on the transcrip- 
tional  activity of NF-KB. Luciferase  activity of the NF-KB-spe- 
cific reporter plasmid  HIV-LTR-Luc was measured in 293 cells 
after cotransfection  of expression  plasmids for Bcl-2, Bcl-x  s, and 
Bcl-xL, as indicated, and stimulation  with TNF to activate endog- 
enous NF-KB. The means of doubly performed experiments are 
shown. 
et al., 1994), we also investigated whether Bcl-2 altered the 
translocation of NF-KB to the nucleus. In immunocytolog- 
ical analyses, we could not detect changes in the intracellu- 
lar localization or expression of NF-KB subunits (data not 
shown).  We could neither obtain evidence for a  physical 
interaction between Bcl-2 and p65 upon immunoprecipita- 
tion of proteins from lysates of transfected cells using ei- 
ther Bcl-2- or p65-specific antibodies  (data  not  shown). 
From these observations, we consider it unlikely that Bcl-2 
interacts  directly with  the  COOH  terminus  of p65,  but 
rather it controls a signaling pathway, causing modulation 
of the transactivating potential of nuclear NF-KB. 
Discussion 
Bcl-2: A Regulator of Gene Expression 
The  molecular mechanism  by which  Bcl-2 protects cells 
Figure 7.  The effect of the ICE inhibitor  CrmA on apoptosis (A) 
and NF-KB activity (B). 293 cells, either untransfected (wt) or sta- 
bly transfected with the neomycin resistance gene (Neo) and two 
CrmA expressing clones (Crm-1, Crm-2), were incubated for 5 d 
in the absence of serum.  Apoptotic cells (A) were visualized as 
described  in Fig.  1 A.  NF-KB activity  (B) was measured after 
transient  transfection  with  an  HIV-LTR controlled  luciferase 
construct as described in Fig. 2 A. 
from apoptosis is poorly understood.  Recent studies have 
suggested that Bcl-2 is a component of a  signal transduc- 
tion  pathway  that  counteracts  the  effects  of  oxidative 
stress (Hockenbery et al., 1993; Kane et al., 1993). This sig- 
naling  pathway  controlled  by  Bcl-2  may  be  related  to 
growth factor-dependent pathways because Bcl-2 can as- 
sociate with the R-Ras protein and Raf-1 kinase (Fernan- 
dez-Sarabia and Bischoff, 1993;  Wang et al., 1994,  1995). 
However, no further component has been identified  that 
could help to unravel the activity of Bcl-2. 
The  potential  involvement  of  ROIs  in  Bcl-2  action 
prompted us to investigate its effect on the activation of 
NF-KB, which might be involved in transcriptional activation 
of "death genes." Numerous reports have documented a 
requirement of ROIs for NF-KB activation. This event in- 
volves the release of the inhibitory subunit IKB from the 
latent  NF-KB  complex in  the  cytoplasm (for review see 
Schreck  et  al.,  1992a;  Meyer  et  al.,  1994;  Baeuerle  and 
Henkel, 1994; Schulze-Osthoff et al., 1995).  In the present 
study, we found that Bcl-2 could indeed attenuate the ac- 
tivity  of NF-KB,  indicating  that  the  transcription  factor 
might be a potential target for the action of a Bcl-2-con- 
trolled pathway. Further  support for this came from our 
finding that the Bcl-2-related protein, Bcl-XL (Boise et al., 
1993),  down-regulated NF-KB  activity, whereas  the  non- 
protective splice variant Bcl-xs was not able to display this 
effect. This suggests that the signaling pathway that leads 
to NF-KB down-regulation is mediated by one of the Bcl-2 
homology domains that are conserved among members of 
the Bcl-2 gene family (Hengartner and Horvitz, 1994; Yin 
et al., 1994; Nunez and Clarke, 1994).  Our data therefore 
demonstrate a hitherto unknown activity of Bcl-2 in con- 
trolling  nuclear gene expression.  A  recent study showed 
that  overexpressed  Bcl-2  was  able  to  inhibit  apoptosis 
even in enucleated cells (Jacobson et al., 1994).  However, 
it cannot be excluded that, in this case, Bcl-2 was protec- 
tive by preventing gene expression before the enucleation 
of cells. 
Oxidative stress interferes with the activation of NF-KB 
by inducing the release of IKB in the cytoplasm. Thus, we 
were surprised that Bcl-2 did not inhibit this step of NF-KB 
activation nor did it affect DNA binding of NF-KB. This 
finding  therefore argues against  an  antioxidant  effect of 
Bcl-2 during NF-KB activation. Instead, we observed that 
Bcl-2 acted on the transactivation domain of the p65 NF-KB 
subunit and thereby repressed KB-dependent transactiva- 
tion  in  the  nucleus.  This represents  a  novel posttransla- 
tional level to control the activity of NF-KB. We have re- 
cently  observed  that,  in  intact  cells,  the  transactivation 
domain  is  phosphorylated  on  serine  residues  (Schmitz, 
M.L., and P.A. Baeuerle, manuscript in preparation). Fu- 
ture  studies  are  required  to  investigate  whether  Bcl-2 
overexpression  induces  changes  in  the  phosphorylation 
status of p65 and whether these allow for regulation of the 
transactivation potential of NF-KB. The level of Bcl-2 ex- 
pression and its ratio to the negative regulatory proteins 
such as Bax (Oltvai et al., 1993) might determine its inter- 
action with R-Ras at intracellular membranes. Analogous 
to growth factor-controlled pathways, the Bcl-2/Ras com- 
plex might then recruite Raf-1 or another protein kinase, 
which  directly or indirectly  leads  to  modification  of nu- 
clear  NF-KB.  Recently,  a  protein  kinase  of 43  kD  was 
The Journal of Cell Biology, Volume 134, 1996  20 Figure 8.  The effect of Bcl-2 on the activation and transcriptional  activity of NF-KB. (A) Inducibility of NF-KB DNA-binding activity in 
cell lines stably overexpressing  Bcl-2. Three Bcl-2 expressing cell clones (see Fig. 1) and the parental cell line were stimulated  for 4 h 
with TNF (200 U/ml). Nuclear cell extracts were prepared and analyzed by EMSA with an NF-KB-specific oligonucleotide  (see Fig. 2 
A). (B) The effect of Bcl-2 overexpression on the transactivation potential of the COOH-terminal part of p65 NF-KB. Six 293 cell clones 
stably expressing Gal4-p65286-55° fusion protein were cotransfected with a Gal4-dependent CAT reporter plasmid together with either 2 
~g RcCMV-Bcl-2  (Bcl-2) or the control plasmid  RcCMV-Luc (-). CAT assays from one series of a representative experiment are 
shown. (C) The effect of Bcl-2 overexpression on the activity of the NF-KB-independent and constitutively  active transactivation  do- 
main VP16. Two 293 clones stably expressing a Ga14-VP16 fusion protein were treated as described  in B. Mean values of two assays of 
Gal4-dependent CAT activity are shown. 
found  associated with  the  cytoplasmic NF-KB-IKB com- 
plex (Hayashi et al.,  1994).  This kinase could be a  candi- 
date for a protein controlling the transcriptional activity of 
p65  because it specifically phosphorylates p65  on  serine 
residues. 
A Potential Role of NF-rB in Apoptosis 
There is increasing evidence that transcription factors of 
the  NF-KB/Rel  family are  involved  in  programmed  cell 
death. First, many potent NF-KB-activating stimuli induce 
apoptosis,  such  as  TNF  (Osborn  et  al.,  1989),  ceramide 
(Schtitze et al., 1992; Obeid et al., 1993),  HeO2 (Schreck et 
al., 1991; Hockenbery et al., 1993), and, as shown here for 
the first time, serum withdrawal. Second, apoptosis can be 
prevented by conditions  that  at  the  same  time  suppress 
NF-KB activation. This has been shown for the antioxidant 
N-acetyl-L-cysteine  and  other  compounds  (Staal  et  al., 
1990;  Schreck  et  al.,  1991;  Schulze-Osthoff et  al.,  1994). 
Third, among the genes induced upon apoptosis are poten- 
tial target genes for NF-KB. Those include the Fas/APO-1 
ligand (Suda et al., 1993; Takahashi et al., 1994), c-myc (La 
Rosa et al., 1994), p53 (Wu and Lozano, 1994),  and ICE 
(Casano et al., 1994). These death genes are transcription- 
ally induced by stimuli activating NF-KB, and, where ana- 
lyzed,  their  upstream promoter regions  harbor potential 
NF-KB-binding motifs. Another target gene for NF-KB is 
encoding its alternative DNA-binding subunit c-Rel. A  re- 
cent report has shown that c-Rel expression is induced in 
apoptotic  cells  in  the  chicken  embryo  (Abbadie  et  al., 
1993).  Here, we could not  observe that  c-Rel is a  major 
component of the NF-KB activity induced upon apoptosis 
in 293 cells. It is possible that c-Rel expression is preferen- 
tially  activated in  lymphoid  cells under  such  conditions. 
From all these observations, it appears that NF-KB partici- 
pates as a signal transducer and gene activator in the pro- 
cess of programmed cell death: apoptotic signals lead to its 
activation,  and  the  activated  transcription  factor  then 
turns on the transcription of genes whose products are re- 
quired to execute the apoptotic program. In this scenario, 
NF-KB only indirectly functions as a "death factor" in that 
it prepares cells for apoptotic stimulation by expression of 
a receptor, a ligand, or other genes with apoptotic activity. 
It should be noted that other apoptotic pathways exist that 
do not require de novo protein synthesis. One example is 
Fas/APO-l-mediated cell death that does not involve NF- 
KB activation (Schulze-Osthoff et al., 1994). 
Because it is clear from many studies that activation of 
NF-KB will not  cause cell death  in  each case, additional 
factors might determine the effect of NF-KB in apoptosis. 
It is  well  established  that  NF-KB  has  to  synergize  with 
other  transcription  factors  in  transcriptional  regulation 
(for review see Baeuerle and Henkel, 1994).  Those unre- 
lated factors might include the steroid receptor Nur77 (Liu 
et al., 1994; Woronicz et al., 1994)  or AP-1 that may syner- 
gize with NF-KB in the regulation of apoptotic genes and 
could specify, for instance,  cell type-specific differences. 
Another determinant for the involvement of NF-KB in ap- 
optosis could be how long the factor is activated. In many 
systems, NF-KB  activation in  response to  TNF or PMA 
stimulation is very transient, lasting only a few hours. No 
apoptotic death  of such cell cultures  has  been  reported. 
The down-regulation of NF-KB activity is most likely me- 
diated by transcriptional activation of inhibitory proteins, 
such  as  IKB-et,  p105,  and  pl00  genes  (Sun  et  al.,  1993, 
1994).  In the present study, we were intrigued to observe 
that  a  p50-p65  NF-KB complex was activated for several 
days after serum withdrawal, suggesting that prolonged ac- 
tivation of the transcription factor may be required to in- 
duce an apoptotic program. There are B and T lymphoma 
cell  lines  containing  constitutive  NF-KB  activity in  their 
nuclei; however, a recent report showed that their nuclear 
NF-KB contained other members of the family, predomi- 
nantly RelB and c-Rel (Lernbecher et al., 1993).  The sub- 
unit composition of NF-KB, which influences DNA-bind- 
ing specificity and transactivating potential (Hansen et al., 
Grimm et al. B¢l-2 and NF-KB  21 1992; Perkins et al.,  1992), might thus be another impor- 
tant determinant controlling the role of NF-KB in apopto- 
sis. Recently, some circumstantial evidence for this notion 
has been presented (Ivanov et al., 1995). 
Our present data might be of relevance for a variety of 
pathological conditions in which apoptosis occurs. In fact, 
NF-KB is activated by a large number of stimuli that in- 
duce  apoptosis  (for  review  see  Baeuerle  and  Henkel, 
1994). For instance, infection of T cells with the HIV-1 or 
T  cell  activation  with  HIV-encoded  proteins,  such  as 
gpl20 or Tat, result in their apoptotic death (Meyaard et 
al., 1992; Ameisen, 1994; Westendorp et al., 1995a,b; Li et 
al.,  1995).  Under the same conditions, NF-KB is activated 
(Hazan et al.,  1990; Westendorp et al.,  1995a). Since the 
expression of HIV-1 is also mediated by NF-KB via two 
binding sites in the long terminal repeat (Nabel and Balti- 
more, 1987), NF-KB could at the same time mediate apop- 
tosis and allow the HIV-1 genome to be expressed and the 
virus escape from dying cells. This would represent a novel 
strategy of HIV to escape cellular defense mechanisms. 
Another example is p65A, a naturally occurring splice vari- 
ant of the p65 NF-KB subunit that acts as a transdominant- 
negative mutant  (Narayanan et al.,  1992).  Expression of 
p65A has been implicated in tumorigenesis, which could be 
explained by an anti-apoptotic activity (Grimm and Bae- 
uerle, 1994). Conditions inhibiting or stably activating NF-KB 
may therefore provide a means to control apoptotic pro- 
cesses. Future experiments will clarify under which cellu- 
lar conditions NF-KB activation is sufficient or necessary 
for apoptosis. 
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